Allurion Technologies (ALUR) Net Cash Flow (2022 - 2026)
Allurion Technologies (ALUR) reported Net Cash Flow of -$355000.0 for Q1 2026, down 107.06% on a YoY basis from $5.0 million in Q1 2025, and up 52.6% quarter-over-quarter from -$749000.0 in Q4 2025.
Allurion Technologies (ALUR) Net Cash Flow (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Net Cash Flow for 5 years, with the latest figure at -$355000.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 107.06% year-over-year to -$355000.0; the trailing twelve-month figure through Mar 2026 stood at -$15.4 million (down 64.18% YoY), and the FY2025 full-year result was -$10.0 million, up 56.06% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$355000.0, up from -$749000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $75.0 million in Q3 2023, with the low at -$41.7 million in Q4 2023.
- Historically, Net Cash Flow has averaged -$295200.0 across 5 years, with a median of -$1.5 million in 2022.
- The largest YoY upside for Net Cash Flow was 29509.02% in 2023 against a maximum downside of 2644.9% in 2023.
- Allurion Technologies' Net Cash Flow stood at -$1.5 million in 2022, then slumped by 2644.9% to -$41.7 million in 2023, then surged by 67.97% to -$13.4 million in 2024, then surged by 94.39% to -$749000.0 in 2025, then surged by 52.6% to -$355000.0 in 2026.
- The last three Net Cash Flow figures came in at -$355000.0 (Q1 2026), -$749000.0 (Q4 2025), and -$6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -355,000.00 |
| Mar 31, 2026 | -355,000.00 |
| Dec 31, 2025 | -749,000.00 |
| Dec 31, 2025 | -749,000.00 |
| Sep 30, 2025 | -6.57 Mn |
| Sep 30, 2025 | -6.57 Mn |
| Jun 30, 2025 | -7.68 Mn |
| Jun 30, 2025 | -7.68 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Dec 31, 2024 | -13.35 Mn |
| Dec 31, 2024 | -13.35 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Sep 30, 2024 | 9.43 Mn |
| Jun 30, 2024 | -10.46 Mn |
| Jun 30, 2024 | -10.46 Mn |
| Mar 31, 2024 | -8.32 Mn |
| Mar 31, 2024 | -8.32 Mn |
| Dec 31, 2023 | -41.70 Mn |
| Dec 31, 2023 | -41.70 Mn |